The Plasmodium falciparum NCR1 transporter is an antimalarial target that exports cholesterol from the parasite’s plasma membrane
2025

PfNCR1 Transporter: A Target for Antimalarial Drugs

publication 10 minutes Evidence: high

Author Information

Author(s): Zhang Zhemin, Lyu Meinan, Han Xu, Bandara Sepalika, Cui Meng, Istvan Eva S., Geng Xinran, Tringides Marios L., Gregor William D., Miyagi Masaru, Oberstaller Jenna, Adams John H., Zhang Youwei, Nieman Marvin T., von Lintig Johannes, Goldberg Daniel E., Yu Edward W.

Primary Institution: Department of Pharmacology, Case Western Reserve University School of Medicine

Hypothesis

The PfNCR1 transporter is essential for cholesterol export in Plasmodium falciparum and could be targeted for antimalarial drug development.

Conclusion

PfNCR1 is capable of exporting cholesterol from the parasite's plasma membrane, making it a promising target for new antimalarial therapies.

Supporting Evidence

  • PfNCR1 was shown to bind cholesterol and form a transport tunnel.
  • Cholesterol efflux assays indicated that PfNCR1 can export cholesterol from the membrane.
  • MMV009108 inhibits PfNCR1, blocking cholesterol transport.

Takeaway

PfNCR1 helps the malaria parasite get rid of cholesterol, which is important for its survival, and blocking this transporter could help fight malaria.

Methodology

The study used single-particle cryo-electron microscopy to determine the structure of the PfNCR1 transporter and conducted cholesterol efflux assays.

Limitations

The study primarily focuses on structural insights and may not fully address the in vivo implications of PfNCR1 inhibition.

Digital Object Identifier (DOI)

10.1126/sciadv.adq6651

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication